As technology has improved, so has airline travel. Nowadays, you can check in for your flight, choose your seats, and even pre-create onboard entertainment playlists via an app on your phone, before ...

Move over em-dash, there’s a new AI giveaway. It’s hard to deny that AI is everywhere these days, and it’s no surprise that it’s making its way into classrooms. Since sneaky students are figuring out ...

Andy Coravos says offloading tedious tasks to AI has freed her to focus more on the things she loves, like singing and playing guitar. Andy Coravos has a new home helper—named Claude. She assigns her ...

[Maximilian Milovidov is a freshman at Columbia University and a member of TikTok's Youth Council. He used a large language model to edit this essay for length and a human to edit for content. This ...

Suffering from hair envy? You can now use the same hair products that Manon, Yoonchae, Sophia, Megan, Lara, and Daniela use to get their glossy locks. Manon's go-to products from Matrix are a ...

Per the terms of the agreement, Novavax will receive an upfront payment of $30 million from Pfizer and is eligible to earn up to $500 million in potential development and commercial milestone payments ...

Novavax secures a non-exclusive licensing deal with Pfizer, validating Matrix-M's platform value and shifting NVAX toward a technology provider model. NVAX receives $30M upfront, a potential $500M in ...

Novavax has agreed to a deal to let Pfizer use Matrix-M adjuvant in its products for an upfront payment of $30 million and up to another $500 million in milestone payments. The biotech company said ...

Pfizer is paying $30 million to use Novavax’s adjuvant technology to improve the efficacy of two of the Big Pharma’s vaccine programs. The tech, called Matrix-M, is designed to trigger an immune ...